Top 5 Mid Cap Companies For 2015

Top 5 Mid Cap Companies For 2015: CollabRx Inc (CLRX)

CollabRx, Inc., incorporated on September 20, 1995, is focused on developing and delivering content knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based precision medicine and big data analytics. The Company delivers content to users through Web-based applications and services in the cloud serving physicians and their patients in two settings: at the point-of-care in the clinic and indirectly, as a part of a genetic test report provided to an ordering physician by a diagnostic testing laboratory, (lab). The Companys Therapy Finder Web-based application serves as an initial user-interface to the underlying knowledge base. It is available free of charge on its Website. In addition, a professional version is offered to registered physicians through MedPage Today, an offering of Everyday Health, Inc.

The Companys offering provides the clinical interpretation of genetic variants present in human tum or biopsies, and is sold directly to diagnostic labs that perform molecular testing on patients. Its Genetic Variant Application (GVA) is compiled by its software platform to provide specific insights to a patients diagnostic test results on a test-by-test basis. The GVA results are provided to laboratories in a variety of forms, including with a front-end user Interface (UI) or directly integrated into a customers laboratory information management system (LIMS). The Companys content is identified as Powered by CollabRx within the test report. Portions of its Web-based applications are available free to physicians and patients through commercial on-line media partners under a license and advertising or sponsorship revenue sharing arrangement. The content that, the Company offers to laboratories is sold based on a variation of Software as a service (SaaS) business model, in which its content is provided on a one-time, subscription or per test basis. It also receives fee-for! -service payments in connection with customized user interfaces to its database.

Advisors' Opinion:

• [By James E. Brumley]

  What do you get when you combine 10,000 different clinical trials trying out 500 cancer drugs against a backdrop of 100,000 new white papers on the topic published every year? In a perfect world all that stuff would almost seem like the foundation for an outright cure for cancer. In reality though, all that data is a recipe for a confusing mess. Thank goodness CollabRx Inc. (NASDAQ:CLRX) is on the scene, straightening out the maddening mess.

• [By James E. Brumley]

  If you were lucky enough to own WebMD Health Corp. (NASDAQ:WBMD) before the end of last week, then congratulations - you're up 20% today. And if you didn't get into WBMD before the close of business on Friday, well, it may be too late to step into it now (unless you like buying overextended stocks), but if you believe in the ongoing convergence of healthcare and digital information though - which is what put WebMD on the map - then you may want to take a closer look at CollabRx Inc. (NASDAQ:CLRX).

• [By Bryan Murphy]

  They say you're known by the caliber of company you keep. If that's true for stocks (and it is), then CollabRx Inc. (NASDAQ:CLRX) has a lot to be proud of with its new partnership with Affymetrix, Inc. (NASDAQ:AFFX). On the flipside, Affymetrix should be honored it's inked a deal with CollabRx. In a combination that hasn't been topped since peanut butter and chocolate hooked up to form a Reese's cup, AFFX and CLRX help bring out the best in each other.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-mid-cap-companies-for-2015.html